RHONDA LYNETTE HELLUMS
CIK 1766456 · Chief Financial Officer · last filed 2026-01-06
RHONDA LYNETTE HELLUMS is a Chief Financial Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for SLN, was dated Jan 6, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLN | Chief Financial Officer | — | $6.69 | — | $0 | 2 | 2026-01-06 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | CHIEF FINANCIAL OFFICER | 0 | — | — | $0 | 2 | 2019-07-18 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | SLN | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | SLN | Grant (A) | — | $0 | EDGAR |
| 2019-07-18 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Disp (D) | −51,424 | $0 | EDGAR |
| 2019-02-05 | ARATANA THERAPEUTICS, INC. (PETX) Delisted | Grant (A) | +24,923 | $0 | EDGAR |